Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Cannabis als Medizin

USA. FDA Approves First Drug Derived from Marijuana

USA. FDA Approves First Drug Derived from Marijuana

Last week, the Food and Drug Administration (FDA) approved Epidiolex® (cannabidiol, or CBD), a medication extracted from marijuana, for the treatment of two severe pediatric seizure disorders, Lennox-Gastaut syndrome and Dravet syndrome. CBD is a compound typically found in very small quantities in the marijuana plant, and it has been of interest to scientists and the public for several years due to its anti-seizure properties and other possible therapeutic benefits. The approval comes at the end of a four-year series of trials showing the benefits of CBD in relieving the symptoms of these seizure disorders, which are highly resistant to existing treatments. (FDA, Nora’s blog, 02.07.2018)

https://www.drugabuse.gov/about-nida/noras-blog/2018/07/fda-approves-first-drug-derived-marijuana